Pentwater Capital Management’s Monogram Orthopaedics MGRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,000
Closed -$58.7K 103
2025
Q3
$58.7K Buy
+10,000
New +$53.4K ﹤0.01% 109

Pentwater Capital Management's MGRM Position: Q4 2025 in Review

Pentwater Capital Management sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 10,000 shares — an estimated $58.7K sold.

Pentwater Capital Management first reported a position in MGRM in Q3 2025 and held it in 1 quarter. The position peaked at $58.7K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Pentwater Capital Management reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Pentwater Capital Management sold 10,000 Monogram Orthopaedics shares in Q4 2025, an estimated $58.7K.
  • Pentwater Capital Management first reported a position in Monogram Orthopaedics in Q3 2025 and held it in 1 quarter.
  • Pentwater Capital Management's Monogram Orthopaedics position peaked at $58.7K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Pentwater Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.